New drug aims to curb heavy periods from fibroids
NCT ID NCT07378098
First seen Feb 01, 2026 · Last updated May 21, 2026 · Updated 12 times
Summary
This study tests a new medication, KLH-2109, to see if it reduces heavy menstrual bleeding in people with uterine fibroids (non-cancerous growths in the uterus). About 254 participants will take either the new drug or a standard treatment pill. Researchers will track bleeding levels and safety through regular clinic visits and diaries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE FIBROIDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.